{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:25:54Z","timestamp":1761895554271,"version":"build-2065373602"},"reference-count":32,"publisher":"Wiley","issue":"11b","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:sec>\n                    <jats:label\/>\n                    <jats:p>\n                      <jats:boxed-text content-type=\"box\" position=\"anchor\">\n                        <jats:p>Study Type \u2013 Diagnostic (case series)<\/jats:p>\n                        <jats:p>Level of Evidence\u20034<\/jats:p>\n                      <\/jats:boxed-text>\n                      <jats:boxed-text content-type=\"box\" position=\"anchor\">\n                        <jats:p>\n                          <jats:bold>What's known on the subject? and What does the study add?<\/jats:bold>\n                        <\/jats:p>\n                        <jats:p>While the relationship between PCA3 score and clinical or histological prostatitis was quite proven even in small patient groups, conversely the relationship between PCA3 score and HG\u2010PIN is still under debate.<\/jats:p>\n                        <jats:p>We demonstrated in a large series (432 patients) that histologically documented chronic prostatitis and HG\u2010PIN have similar PCA3 scores to patients with BPH and\/or normal parenchyma at biopsy.<\/jats:p>\n                      <\/jats:boxed-text>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            To determine whether histological chronic prostatitis and high\u2010grade prostate intra\u2010epithelial neoplasia (\n                            <jats:styled-content style=\"fixed-case\">HG\u2010PIN<\/jats:styled-content>\n                            ) influence the prostate cancer gene 3 (\n                            <jats:styled-content style=\"fixed-case\">PCA3<\/jats:styled-content>\n                            ) score in\n                            <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>\n                            talian patients with an elevated prostate\u2010specific antigen (\n                            <jats:styled-content style=\"fixed-case\">PSA<\/jats:styled-content>\n                            ) level and a negative digital rectal examination (\n                            <jats:styled-content style=\"fixed-case\">DRE<\/jats:styled-content>\n                            ) who were undergoing a first or repeat prostate biopsy.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            A urinary\n                            <jats:styled-content style=\"fixed-case\">PCA3<\/jats:styled-content>\n                            test was prospectively performed in 432 consecutive patients who were admitted to\n                            <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>\n                            radenigo\n                            <jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>\n                            ospital (\n                            <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\n                            urin,\n                            <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>\n                            taly) between\n                            <jats:styled-content style=\"fixed-case\">J<\/jats:styled-content>\n                            anuary and\n                            <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\n                            ecember 2011 and scheduled for first or repeat prostate biopsy as a result of an elevated\n                            <jats:styled-content style=\"fixed-case\">PSA<\/jats:styled-content>\n                            level and negative\n                            <jats:styled-content style=\"fixed-case\">DRE<\/jats:styled-content>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            A comparison of the\n                            <jats:styled-content style=\"fixed-case\">PCA3<\/jats:styled-content>\n                            score and patients with a negative biopsy (normal parenchyma, benign prostatic hyperplasia, chronic prostatitis,\n                            <jats:styled-content style=\"fixed-case\">HG\u2010PIN<\/jats:styled-content>\n                            ) or positive biopsy was performed.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:styled-content style=\"fixed-case\">PCA3<\/jats:styled-content>\n                            median (range) scores varied significantly (\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.001) in men with a negative vs positive biopsy\n                            <jats:bold>:<\/jats:bold>\n                            33 (2\u2013212) and 66 (5\u2013324), respectively.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            By contrast, men with chronic prostatitis and\n                            <jats:styled-content style=\"fixed-case\">HG\u2010PIN<\/jats:styled-content>\n                            showed no significant difference with respect to\n                            <jats:styled-content style=\"fixed-case\">PCA3<\/jats:styled-content>\n                            score compared to other negative biopsy patients.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            No correlation was found between the number of positive cores for chronic prostatitis,\n                            <jats:styled-content style=\"fixed-case\">HG\u2010PIN<\/jats:styled-content>\n                            and\n                            <jats:styled-content style=\"fixed-case\">PCA3<\/jats:styled-content>\n                            score.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Of all patients with a positive biopsy, 23 (20%) of 114 men had a\n                            <jats:styled-content style=\"fixed-case\">PCA3<\/jats:styled-content>\n                            score \u226435.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            In total, 79 (40%) of 197 men with a negative biopsy (normal parenchyma and benign prostatic hyperplasia), 24 (37.5%) of 64 men with chronic prostatitis and 19 (39.6%) of 48 men with\n                            <jats:styled-content style=\"fixed-case\">HG\u2010PIN<\/jats:styled-content>\n                            had a\n                            <jats:styled-content style=\"fixed-case\">PCA3<\/jats:styled-content>\n                            score &gt;35.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            At this early stage of clinical evaluation, cancer specificity of the urinary\n                            <jats:styled-content style=\"fixed-case\">PCA3<\/jats:styled-content>\n                            test appears to be maintained in the face of chronic prostatitis and\n                            <jats:styled-content style=\"fixed-case\">HG\u2010PIN<\/jats:styled-content>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2012.11645.x","type":"journal-article","created":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T07:16:41Z","timestamp":1351754201000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Histological chronic prostatitis and high\u2010grade prostate intra\u2010epithelial neoplasia do not influence urinary prostate cancer gene 3 score"],"prefix":"10.1111","volume":"110","author":[{"given":"Stefano","family":"De Luca","sequence":"first","affiliation":[{"name":"Division of Urology Gradenigo Hospital  Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Passera","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine 2 San Giovanni Battista Hospital and University of Torino  Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Milillo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Gradenigo Hospital  Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Coda","sequence":"additional","affiliation":[{"name":"Department of Pathology Gradenigo Hospital and University of Torino  Torino Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donato Franco","family":"Randone","sequence":"additional","affiliation":[{"name":"Division of Urology Gradenigo Hospital  Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,11]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"5975","article-title":"A new prostate\u2010specific gene, highly over expressed in prostate cancer","volume":"59","author":"Bussemakers MJ","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0302-2838(03)00201-X"},{"key":"e_1_2_6_4_1","first-page":"695","article-title":"DD3(PCA3), a very sensitive and specific marker to detect prostate tumors","volume":"62","author":"Kok JB","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(03)00759-3"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.06.071"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.063289"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.11.038"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2004.06.004"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.21457"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.04.017"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0b013e328344939c"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2004.10.046"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.51"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200969010-00005"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.57.011205.135654"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2090"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.04.033"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.07.028"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1159\/000020161"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.04007.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)00337-X"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800053"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.07.093"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540420048028"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.06.038"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.11.044"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.01.075"},{"key":"e_1_2_6_29_1","first-page":"96","article-title":"Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer. A validation study on an itaian population undergoing first and repeat biopsy","volume":"34","author":"Bollito E","year":"2012","journal-title":"Anal Quant Cytol Histol"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24447"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.09.035"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-010-0580-0"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.09.030"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2012.11645.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2012.11645.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:22:58Z","timestamp":1761736978000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2012.11645.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":32,"journal-issue":{"issue":"11b","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1111\/j.1464-410X.2012.11645.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2012.11645.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"type":"print","value":"1464-4096"},{"type":"electronic","value":"1464-410X"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"2012-09-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-11-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}